An interventional study of Exercise Program and Exercise plus graded motor imagery in Ankle Osteoarthritis and Foot Osteoarthritis, sponsored by Alanya Alaaddin Keykubat University. Recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-30.
Sponsored by Alanya Alaaddin Keykubat University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 106 studies in Osteoarthritis with a site in Turkey — 22 open to participants now, 29 under way, none of them phase 3. Osteoarthritis · Turkey.
Among the 106 studies in Osteoarthritis with a site in Turkey, this one is the 61st largest by planned enrollment of the 64 interventional ones that give a count, is one of 14 that started in 2026, is one of 60 with no phase, reaches primary completion later than 19 of the 28 other live ones, and was the 90th registered.
2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.
Browse Osteoarthritis studies →22 of the 106 studies in Osteoarthritis with a site in Turkey are open now. Recruiting first, the newest first:
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · Sites in Turkey
Ages 45–65
Dokuz Eylul University · Sites in Turkey
Ages 40–70 · Healthy volunteers
Hacettepe University · Sites in Turkey
Ages 25–74
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18–80
Kayseri City Hospital · Sites in Turkey
Ages 40–75
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
106 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 14 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 24 is below the median of 80 across 2,242 interventional studies indexed under Osteoarthritis.
Median enrollment 54 across the 64 interventional studies, 84 across the 42 observational. Of the 73 that completed or were terminated, 2 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 106 have an industry lead sponsor. The 10 most frequent:
Alanya Alaaddin Keykubat University is the lead sponsor of 51 studies on the registry; 17 are open to participants now.
Alanya Alaaddin Keykubat University has 1 study filed under Osteoarthritis — fewer than ten, so there is no comparison to draw.
10 of the studies in Osteoarthritis with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07678996Kayseri City HospitalDose-Response Effect of Intra-Articular Ozone in Knee Osteoarthritis | 2026-11-30 |
| NCT07517614SB Istanbul Education and Research HospitalCondylar Offset and Outcomes in Primary Total Knee Arthroplasty | 2026-12 |
| NCT07522060Hacettepe UniversityEarly Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Using a Digital Monitoring System | 2026-12-30 |
| NCT07417436Alanya Alaaddin Keykubat UniversityEffects of Graded Motor Imagery in Individuals With Foot/Ankle Osteoarthritis | 2026-12-30 |
| NCT07360093Ankara City Hospital BilkentPENG Block & PENG PRF | 2027-02-01 |
Add all 10 to your calendar (.ics) → With an account.
Among the 106 studies in Osteoarthritis with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of our study is to evaluate the effects of graded motor imagery training applied in addition to a structured exercise program in individuals with foot and/or ankle osteoarthritis.
The study population will consist of twenty-four individuals diagnosed with foot/ankle osteoarthritis who applied to the Orthopedics and Traumatology Department of Alanya Alaaddin Keykubat University Education and Research Hospital.
Individuals who volunteer to participate in the study will be invited to participate through face-to-face interviews. The inclusion and exclusion criteria are as follows:
Inclusion criteria:
Exclusion criteria:
The results of this study may help improve physiotherapy programs for individuals with similar health conditions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Exercise Program
Behavioral: Exercise plus graded motor imagery
During this intervention, participants will take part in a structured physiotherapy exercise program. The program will be delivered under the guidance of a physiotherapist.
During this intervention, participants will take part in the same physiotherapy exercise program combined with educational sessions.
Socio-demographic assessment form
The names, ages, genders, heights, body weights, dominant side of the lower extremity, occupations, education levels, and medication use of individuals who wish to participate in the study on a voluntary basis will be recorded, along with their phone numbers so that they can be contacted again if necessary. Radiological findings, age, and disease duration will also be included in the clinical evaluation form for individuals with foot/ankle osteoarthritis.
Time frame: Baseline and after 6 weeks
Pain Intensity Assessment
Patients' rest, activity, and night pain will be assessed using the Numerical Rating Pain Scale (NPRS). The NPRS is an 11-point scale scored from 0 to 10. A score of zero (0) indicates "no pain," while a score of 10 indicates "the most severe pain imaginable." Participants will be asked to mark the appropriate score on this scale for their foot/ankle pain.
Time frame: Baseline and after 6 weeks
Pain Threshold Measurement
In this study, the pressure pain threshold (PPT) is defined as the amount of pressure (kg/cm²) at which pressure sensation is converted into pain. PPT measurements will be performed using a mechanical pressure algometer (Commander™ Algometer, JTECH Medical, Inc.). During the measurements, participants will be asked to verbally inform the tester when the applied pressure first causes pain. The device used has a force gauge that measures force in kilograms (kg) and a round rubber tip with a diameter of 1 cm². Pressure application will be performed at a rate of approximately 0.1 kg/cm²/s. Three repetitions will be performed for each anatomical region, and the average of the measurements will be used in the analyses. A 30-second rest period will be provided between each measurement. During foot measurements, participants will be placed in a long sitting position, and the foot being evaluated will be stabilized by the examiner. Referencing Cavanagh (1987), pressure will be applied to the m
Time frame: Baseline and after 6 weeks
Gait Analysis
The BTS G-Walk® Spatio-Temporal Gait Analysis System will be used for gait analysis in the study. Measurements will be performed on a predetermined 10-meter flat walking track . The BTS G-Walk® system works with a wireless sensor (analysis port) placed at the patient's L4-L5 or L5-S1 vertebra level via an elastic belt, and measurement data is transferred to the computer via a Bluetooth connection. This system allows clinicians to analyze spatio-temporal walking parameters obtained during walking, general walking kinematics, and pelvic and spinal movements in three planes. The BTS G-Walk® system provides a detailed analysis by comparing data from the right and left lower extremities with normative values during gait analysis and ensures reliable measurements
Time frame: Baseline and after 6 weeks
Foot Function Index
The Foot Function Index is a self-administered questionnaire that assesses multiple dimensions of foot function. The FFI consists of 23 items divided into three subscales that measure the impact of foot pathology on pain, disability, and activity limitation. The minimum change of clinical significance is 7 points for the total scale. The Foot Function Index is widely used in various pathologies and treatments related to foot and ankle problems, such as congenital, acute and chronic diseases, injuries, and surgical corrections .
Time frame: Baseline and after 6 weeks
Laterality assessment
Laterization assessment will be performed using the Recognise™ application developed by the Neuro Orthopaedic Institute (NOI). There are versions specific to different parts of the body. The "Recognise™ Foot" application will be used in this thesis study. Using the "Vanilla" mode of the NOI program, foot photos will be presented to participants in random order via their phones. Participants will be asked to indicate whether the image shown belongs to the right or left foot. Both response accuracy and reaction time will be recorded during this assessment. Accuracy will be defined as the percentage of images correctly identified; reaction time will represent the time taken by the participant to distinguish between the right and left foot. If participants cannot respond within 5 seconds to four or more consecutive images, this will be considered inattention, and the test will be repeated. The lateralization assessment will be performed three times for each participant, and the avera
Time frame: Baseline and after 6 weeks
Joint position sense assessment
In this study, a universal goniometer, a method recognized in the literature as valid and reliable for Ankle Joint Position Sense (AJPS) assessment, will be used. During the assessment, individuals will be placed in a supine position and their eyes will be closed to eliminate visual cues. The pivot of the goniometer will be placed 1.5 cm below the lateral malleolus, the fixed arm will be parallel to the long axis of the fibula, and the movable arm will be parallel to the long axis of the 5th metatarsal. During this measurement, the goniometer will not come into contact with the individual. During the test, three target angles will be selected from the 10° dorsiflexion, 10° plantar flexion, and 20° plantar flexion angles, which are frequently used in the literature and are important for walking function. The subjects' feet in the neutral position will be brought to the specified target angles, and they will be asked to focus on their ankle positions for 5 seconds. This process will be
Time frame: Baseline and after 6 weeks
Foot Pressure Assessment
Measurements will be taken using a pedobarography device to assess foot pressure in a static position. Participants will be given detailed information about the procedure and the measurement process will be explained prior to the measurement. To help participants maintain their balance and focus their attention during the measurement, a point will be marked on the wall three meters ahead, and participants will be asked to focus on this point throughout the measurement. The data displayed on the device screen when participants achieve their balance position will be recorded. As part of the evaluation, the following data will be recorded for analysis: total foot pressure, forefoot pressure, rearfoot pressure , and surface area for the dominant and non-dominant sides.
Time frame: Baseline and after 6 weeks
Kinesiophobia Assessment
The Tampa Kinesiophobia Scale (TKS) will be used in the kinesiophobia assessment. The TKS is a 17-item measure consisting of questions related to fear of re-injury, pain anxiety, and fear-avoidance behaviors. Each item is scored using a 4-point Likert scale ranging from 1 to 4, but items 4, 8, 12, and 16 are reverse-scored. The total score ranges from 17 to 68 points; higher scores indicate a higher level of kinesiophobia.
Time frame: Baseline and after 6 weeks
Quality of Life Assessment
The Nottingham Health Profile (NHP) will be used to assess participants' health-related quality of life. It is a measure developed to assess an individual's health status in terms of physical, emotional, and social aspects. The questionnaire assesses six dimensions related to health status: pain (8 items), emotional reactions (9 items), energy (3 items), social isolation (5 items), sleep (5 items), and physical activity (8 items). It consists of a total of 38 questions answered as yes (1 point)/no (0 points) (Appendix-6). A score between 0 and 100 can be obtained from each subcategory. '0' indicates no limitation, while '100' indicates the presence of all listed limitations.
Time frame: Baseline and after 6 weeks
Patient Satisfaction Assessment
The Global Rating of Change (GRC) scale will be used for patient satisfaction assessment. This scale will be used to measure the effect of the treatment process on participants' overall health status and the level to which their individual expectations are met. Participants will be asked to indicate the change they feel in their health status after treatment compared to before treatment.
Time frame: End of the intervention
Central Sensitization Assessment
The central sensitization assessment will be conducted using the Central Sensitization Inventory (CSI). This inventory is an assessment tool used to identify individuals with symptoms related to central sensitization and to screen for clinical conditions associated with central sensitization syndrome (CSS), such as fibromyalgia, temporomandibular joint disorder, tension-type headache, and migraine. The CSI consists of two sections: Section A consists of 25 items that inquire about symptoms specific to central sensitization syndrome. Participants rate each item on a scale of 0 to 4. The total score obtained from this section ranges from 0 to 100, with scores of 40 and above indicating the presence of central sensitization. Section B contains questions aimed at determining whether the participant has previously been diagnosed with psychiatric conditions such as anxiety or depression, or with diseases associated with the CNS.
Time frame: Baseline and after 6 weeks
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2026 (actual). Primary completion is estimated for Dec 2026, 9 months after the start.
Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 9 months is below that.
Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.
Start moved once since we started tracking on Sep 25, 2026: Aug 2025 → Mar 2026, on Oct 30, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Alanya Alaaddin Keykubat University